Department of Obstetrics and Gynecology, Department of Physiology and Pharmacology, and The Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239.
J Neurosci. 2013 Oct 9;33(41):16158-69. doi: 10.1523/JNEUROSCI.2001-13.2013.
Premature and long-term ovarian hormone loss following ovariectomy (OVX) is associated with cognitive impairment. This condition is prevented by estradiol (E2) therapy when initiated shortly following OVX but not after substantial delay. To determine whether these clinical findings are correlated with changes in synaptic functions, we used adult OVX rats to evaluate the consequences of short-term (7-10 d, OVXControl) and long-term (∼5 months, OVXLT) ovarian hormone loss, as well as subsequent in vivo E2 treatment, on excitatory synaptic transmission at the hippocampal CA3-CA1 synapses important for learning and memory. The results show that ovarian hormone loss was associated with a marked decrease in synaptic strength. E2 treatment increased synaptic strength in OVXControl but not OVXLT rats, demonstrating a change in the efficacy for E2 5 months following OVX. E2 also had a more rapid effect: within minutes of bath application, E2 acutely increased synaptic strength in all groups except OVXLT rats that did not receive in vivo E2 treatment. E2's acute effect was mediated postsynaptically, and required Ca(2+) influx through the voltage-gated Ca(2+) channels. Despite E2's acute effect, synaptic strength of OVXLT rats remained significantly lower than that of OVXControl rats. Thus, changes in CA3-CA1 synaptic transmission associated with ovarian hormone loss cannot be fully reversed with delayed E2 treatment. Given that synaptic strength at CA3-CA1 synapses is related to the ability to learn hippocampus-dependent tasks, these findings provide additional insights for understanding cognitive impairment-associated long-term ovarian hormone loss and ineffectiveness for delayed E2 treatment to maintain cognitive functions.
卵巢切除(OVX)后过早和长期的卵巢激素丧失与认知障碍有关。这种情况可以通过在 OVX 后不久开始的雌二醇(E2)治疗来预防,但在大量延迟后则不行。为了确定这些临床发现是否与突触功能的变化相关,我们使用成年 OVX 大鼠来评估短期(7-10d,OVXControl)和长期(约 5 个月,OVXLT)卵巢激素丧失以及随后体内 E2 治疗对海马 CA3-CA1 突触兴奋性突触传递的影响,该突触对于学习和记忆很重要。结果表明,卵巢激素丧失与突触强度的明显下降有关。E2 治疗增加了 OVXControl 大鼠的突触强度,但没有增加 OVXLT 大鼠的突触强度,表明在 OVX 后 5 个月 E2 的疗效发生了变化。E2 还具有更快的作用:在浴液应用后的几分钟内,E2 急性增加了所有组的突触强度,除了没有接受体内 E2 治疗的 OVXLT 大鼠。E2 的急性作用是通过突触后机制介导的,需要通过电压门控钙(Ca2+)通道进行 Ca2+内流。尽管 E2 具有急性作用,但 OVXLT 大鼠的突触强度仍然明显低于 OVXControl 大鼠。因此,与卵巢激素丧失相关的 CA3-CA1 突触传递的变化不能通过延迟的 E2 治疗完全逆转。鉴于 CA3-CA1 突触的突触强度与学习海马依赖任务的能力有关,这些发现为理解与长期卵巢激素丧失相关的认知障碍以及延迟 E2 治疗维持认知功能的无效性提供了更多的见解。